Norman Noble enhances medical implant quality and efficiency

Norman Noble has implemented cutting-edge robotic electropolishing technology at one of its Ohio facilities. This state-of-the-art system is a fully automated, closed-loop process that eliminates human intervention, ensuring repeatability and efficiency in finishing metallic-based medical implants. By leveraging advanced robotics and process control, Norman Noble continues to set the benchmark for precision finishing in medical device manufacturing.

Electropolishing is a vital post-processing step that enhances surface finish, improves corrosion resistance, and removes micro-burrs from complex geometries. The integration of robotics into this process mitigates variability associated with manual operation, delivering uniform, high-quality results across high-volume production runs.

“The addition of fully automated robotic electropolishing aligns with our strategic initiatives to enhance quality and reduce costs for our customers,” says Eric Lehuta, director of engineering at Norman Noble. “By eliminating human variability, we achieve the consistency and precision required for intricate stent designs and other high-performance medical implants. This advanced automation ensures unparalleled repeatability and process control, ultimately improving manufacturing efficiency and delivering superior product quality to our customers.”

With this latest advancement, Norman Noble further strengthens its position as a premier contract manufacturer for medical device and implant OEMs, offering vertically integrated solutions that encompass micromachining, laser processing, advanced finishing, and quality inspection. The company’s continued investment in robotics highlights its dedication to pushing the boundaries of manufacturing innovation, optimizing production workflows, and delivering superior quality products for its customers.